Medtronic Plc

NYSE:MDT  
105.61
-0.50 (-0.47%)
Earnings Announcements

Medtronic Announces Results Showing Meaningful Pain Relief Using DTM Spinal Cord Stimulation Endurance Therapy

Published: 01/14/2022 17:10 GMT
Medtronic Plc (MDT) - Medtronic Announces Results Showing Meaningful Pain Relief Using Dtm™ Spinal Cord Stimulation Endurance Therapy.
Medtronic Plc - Dtm Scs Endurance Therapy Enables Long-lasting Recharge-free Performance on Vanta and 5-minute Recharge on Intellis Neurostimulators.
Medtronic - 3-month Data Shows Therapy Enables Between 5.5-7.5 Years Device Longevity When Programmed on Vanta Recharge-free Neurostimulator.
Revenue is expected to be $7.93 Billion
Adjusted EPS is expected to be $1.37

Next Quarter Revenue Guidance is expected to be $8.54 Billion
Next Quarter EPS Guidance is expected to be $1.58

More details on our Analysts Page.